Peng Lu
Fortune : 2 M $ au 31/05/2026
Fortune : 2 M $ au 31/05/2026
Peng Lu currently works at Pharvaris NV, as Chief Medical Officer & Head-Research & Technology from 2024.
Dr. Lu also formerly worked at Takeda Nederland BV, as Vice President.
Dr. Lu received her doctorate degree from Beijing Medical University and doctorate degree from the University of Texas at Austin Graduate School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PHARVARIS N.V. 0,09 % | 18/06/2026 | 65 631 ( 0,09 % ) | 2 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PHARVARIS N.V. | Directeur Technique/Scientifique/R&D | 07/02/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
Takeda Nederland BV
Takeda Nederland BV Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Beijing Medical University
Beijing Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Nederland BV
Takeda Nederland BV Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Pharvaris NV
Pharvaris NV BiotechnologyHealth Technology Develops and commercializes oral bradykinin B2 receptor antagonists | Health Technology |
University of Texas at Austin Graduate School
University of Texas at Austin Graduate School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national